Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients.

Landier W, Ahern J, Barakat LP, Bhatia S, Bingen KM, Bondurant PG, Cohn SL, Dobrozsi SK, Haugen M, Herring RA, Hooke MC, Martin M, Murphy K, Newman AR, Rodgers CC, Ruccione KS, Sullivan J, Weiss M, Withycombe J, Yasui L, Hockenberry M.

J Pediatr Oncol Nurs. 2016 Nov/Dec;33(6):422-431. doi: 10.1177/1043454216655983. Epub 2016 Jul 9.

2.

Reconsidering Physical Activity Restrictions for Mononephric Survivors of Childhood Cancer: A Report From the Children's Oncology Group.

Okada M, Hockenberry MJ, Koh CJ, Meeske KA, Rangan KE, Rodgers C, Rosenthal Y, Ruccione KS, Freyer DR.

J Pediatr Oncol Nurs. 2016 Jul;33(4):306-13. doi: 10.1177/1043454215607341. Epub 2015 Nov 20. Review.

3.

Characterization of transfusion-derived iron deposition in childhood cancer survivors.

Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1913-9. doi: 10.1158/1055-9965.EPI-14-0292. Epub 2014 Jun 24.

4.

Children's Oncology Group's 2013 blueprint for research: nursing discipline.

Landier W, Leonard M, Ruccione KS.

Pediatr Blood Cancer. 2013 Jun;60(6):1031-6. doi: 10.1002/pbc.24415. Epub 2012 Dec 19. Review.

5.

PROMIS pediatric measures in pediatric oncology: valid and clinically feasible indicators of patient-reported outcomes.

Hinds PS, Nuss SL, Ruccione KS, Withycombe JS, Jacobs S, DeLuca H, Faulkner C, Liu Y, Cheng YI, Gross HE, Wang J, DeWalt DA.

Pediatr Blood Cancer. 2013 Mar;60(3):402-8. doi: 10.1002/pbc.24233. Epub 2012 Jul 24.

PMID:
22829446
6.

Cancer survivor identity shared in a social media intervention.

Song H, Nam Y, Gould J, Sanders WS, McLaughlin M, Fulk J, Meeske KA, Ruccione KS.

J Pediatr Oncol Nurs. 2012 Mar-Apr;29(2):80-91. doi: 10.1177/1043454212438964.

PMID:
22472482
7.

Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors.

Ruccione KS, Mudambi K, Sposto R, Fridey J, Ghazarossian S, Freyer DR.

Pediatr Blood Cancer. 2012 Oct;59(4):697-702. doi: 10.1002/pbc.24046. Epub 2011 Dec 20.

PMID:
22190481
8.

Creating a novel structure for nursing research in a cooperative clinical trials group: the Children's Oncology Group experience.

Ruccione KS, Hinds PS, Wallace JD, Kelly KP; Children's Oncology Group Nursing Discipline.

Semin Oncol Nurs. 2005 May;21(2):79-88. Review.

PMID:
15991659
9.

Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.

Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD, Blatt J, Constine LS, Freeman CR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM.

J Clin Oncol. 2004 Dec 15;22(24):4979-90. Epub 2004 Dec 2.

PMID:
15576413
10.

Coming to terms with language. Mara Mogensen Flaherty Memorial Lecture.

Ruccione KS.

Oncol Nurs Forum. 2004 Sep 17;31(5):913-25. Print 2004 Sep. No abstract available.

PMID:
15378092
11.

Research triangulation to derive meaning-based quality-of-life theory: adolescent resilience model and instrument development.

Haase JE, Heiney SP, Ruccione KS, Stutzer C.

Int J Cancer Suppl. 1999;12:125-31.

PMID:
10679883
12.

Informed consent in pediatric oncology: a nursing perspective.

Ruccione KS.

J Pediatr Oncol Nurs. 1994 Jul;11(3):128-33. No abstract available.

PMID:
7917140
13.

Bringing childhood cancer information to the community: a "traveling roadshow" for school nurses.

Ruccione KS, Britt B.

J Pediatr Oncol Nurs. 1994 Apr;11(2):88-90. No abstract available.

PMID:
8003266
14.

What caused my child's cancer? Parents' responses to an epidemiology study of childhood cancer.

Ruccione KS, Waskerwitz M, Buckley J, Perin G, Hammond GD.

J Pediatr Oncol Nurs. 1994 Apr;11(2):71-84.

PMID:
8003264
15.

Wilms' tumor: a paradigm, a parallel, and a puzzle.

Ruccione KS.

Semin Oncol Nurs. 1992 Nov;8(4):241-51. Review.

PMID:
1336210
16.

A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Childrens Cancer Study Group.

Ettinger LJ, Ru N, Krailo M, Ruccione KS, Krivit W, Hammond GD.

J Neurooncol. 1990 Aug;9(1):69-76.

PMID:
2213117
17.

A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.

Ettinger LJ, Ru N, Krailo MD, Ruccione KS, Krivit WA, Hammond GD.

Am J Pediatr Hematol Oncol. 1990 Fall;12(3):301-5.

PMID:
2240475
18.

A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.

Ettinger LJ, Krailo M, Ruccione KS, Krivit W, Hammond GD.

Am J Pediatr Hematol Oncol. 1988 Spring;10(1):18-22.

PMID:
3189713
19.

Cancer chemotherapy in children: nursing issues and approaches.

Meeske K, Ruccione KS.

Semin Oncol Nurs. 1987 May;3(2):118-27. No abstract available.

PMID:
3646723
20.

Phase I clinical evaluation of diaziquone in childhood cancer.

Ettinger LJ, Siegel SE, Belasco JB, Evans AE, Ruccione KS, Jamin DC, Rohrbaugh TM, Higgins GR.

Cancer Treat Rep. 1985 Mar;69(3):323-7.

PMID:
3856480

Supplemental Content

Loading ...
Support Center